Amaris Elliott Engel

October 28, 2014 | National Law Journal

A dialysis clinic has moved to dismiss a Missouri plaintiff's lawsuit from federal multidistrict litigation over dialysis products. The clinic's counsel argues that the plaintiff cannot stick with products liability claims and actually must meet the higher standards of a claim for medical malpractice.

By Amaris Elliott-Engel

2 minute read

October 28, 2014 | National Law Journal

The Montana Supreme Court has granted a new trial in a products liability lawsuit over a liquid acrylic nail product.

By Amaris Elliott-Engel

3 minute read

October 27, 2014 | National Law Journal

One of these days San Francisco Superior Court Judge Richard Kramer says he's going to write down every proposition that the U.S. Supreme Court's class-action ruling in Wal-Mart v. Dukes is cited for and read them out loud. And his audience is going to laugh, the judge said.

By Amaris Elliott-Engel

3 minute read

October 27, 2014 | National Law Journal

C.R. Bard Inc., a manufacturer of transvaginal mesh facing close to 10,000 cases in federal court, has moved to disqualify one of the plaintiffs' experts.

By Amaris Elliott-Engel

2 minute read

October 23, 2014 | National Law Journal

The Consumer Product Safety Commission is mulling whether to adopt mandatory safety standards for recreational off-highway vehicles.

By Amaris Elliott-Engel

3 minute read

October 23, 2014 | National Law Journal

A federal judge has struck a report Takeda Pharmaceuticals U.S.A. filed with the court indicating it was on track to restore evidence in an Actos case that resulted in a $9 billion verdict.

By Amaris Elliott-Engel

2 minute read

October 23, 2014 | National Law Journal

The U.S. Court of Appeals for the Sixth Circuit has upheld a $5 million verdict issued in a mass tort in which plaintiffs alleged that GE Healthcare Inc. failed to warn that a gadolinium-based contrast agent used in MRIs can cause the growth of painful excess fibrous tissue in patients with failing kidneys.

By Amaris Elliott-Engel

2 minute read

October 23, 2014 | National Law Journal

A cybersecurity framework for medical devices and health-care technology needs to be developed in a partnership between the government, manufacturers and health-care providers, officials from across the public and private sectors during a workshop con-vened by the U.S. Food and Drug Administration.

By Amaris Elliott-Engel

2 minute read

October 22, 2014 | National Law Journal

In a case of first impression, a federal judge has ruled that Georgia plaintiffs cannot sue over design defects in drugs that have been approved by the U.S. Food and Drug Administration.

By Amaris Elliott-Engel

2 minute read

October 22, 2014 | National Law Journal

Plaintiffs lawyers fighting Takeda Pharmaceuticals U.S.A. over the drugmaker's spoliation of evidence have denounced as a “whitewash” its recent claim that it is on track to restore the evidence.

By Amaris Elliott-Engel

2 minute read